157 related articles for article (PubMed ID: 32762074)
1. Switching antiepileptic drugs to once-daily dosing regimens in epilepsy patients.
Kim SH; Lee H; Kim DW
Acta Neurol Scand; 2021 Jan; 143(1):51-55. PubMed ID: 32762074
[TBL] [Abstract][Full Text] [Related]
2. Why are antiepileptic drugs continued after successful epilepsy surgery in adults?
Foged MT; Stefánsdóttir A; Brændgaard M; Holm E; Pinborg LH; Sabers A
Epilepsy Behav; 2019 Nov; 100(Pt A):106452. PubMed ID: 31655373
[TBL] [Abstract][Full Text] [Related]
3. Patterns of antiepileptic drug use in patients with potential refractory epilepsy in Texas Medicaid.
Gupte-Singh K; Wilson JP; Barner JC; Richards KM; Rascati KL; Hovinga C
Epilepsy Behav; 2018 Oct; 87():108-116. PubMed ID: 30120071
[TBL] [Abstract][Full Text] [Related]
4. Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
Poolos NP; Castagna CE; Williams S; Miller AB; Story TJ
Epilepsy Behav; 2017 Apr; 69():59-68. PubMed ID: 28235655
[TBL] [Abstract][Full Text] [Related]
5. Medication use in poststroke epilepsy: A descriptive study on switching of antiepileptic drug treatment.
Bekelaar K; van Tuijl JH; van Raak EPM; van Oostenbrugge RJ; Aldenkamp AP; Rouhl RPW
Epilepsy Behav; 2020 Mar; 104(Pt B):106434. PubMed ID: 31477535
[TBL] [Abstract][Full Text] [Related]
6. Extended-release formulations for the treatment of epilepsy.
Bialer M
CNS Drugs; 2007; 21(9):765-74. PubMed ID: 17696575
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Pazdera L; Sperling MR; Harvey JH; Sam MC; Strom LA; Blum D; Grinnell T; Cheng H
Epilepsia; 2018 Mar; 59(3):704-714. PubMed ID: 29450890
[TBL] [Abstract][Full Text] [Related]
8. Relationship of antiepileptic drugs to generic brittleness in patients with epilepsy.
Das S; Jiang X; Jiang W; Ting TY; Polli JE
Epilepsy Behav; 2020 Apr; 105():106936. PubMed ID: 32092462
[TBL] [Abstract][Full Text] [Related]
9. The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.
Mitelpunkt A; Kramer U; Hausman Kedem M; Zilbershot Fink E; Orbach R; Chernuha V; Fattal-Valevski A; Deutsch L; Heffetz D; Sacks H
Epilepsy Behav; 2019 Sep; 98(Pt A):233-237. PubMed ID: 31394352
[TBL] [Abstract][Full Text] [Related]
10. Retention of perampanel in adults with pharmacoresistant epilepsy at a single tertiary care center.
Wehner T; Mannan S; Turaga S; Vallabhaneni K; Yip HM; Wiggans C; Shankar R; Duncan JS; Sander JW
Epilepsy Behav; 2017 Aug; 73():106-110. PubMed ID: 28624720
[TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy.
Kim YD; Heo K; Park SC; Huh K; Chang JW; Choi JU; Chung SS; Lee BI
Epilepsia; 2005 Feb; 46(2):251-7. PubMed ID: 15679506
[TBL] [Abstract][Full Text] [Related]
12. Factors influencing medication adherence after epilepsy surgery.
Liu J; Xu R; Liu Z; You Y; Meng F
Epileptic Disord; 2015 Mar; 17(1):47-51; quiz 51. PubMed ID: 25644456
[TBL] [Abstract][Full Text] [Related]
13. Risk of hospitalization among patients with epilepsy using long versus short half-life adjunctive antiepileptic drugs.
Cramer JA; Yan T; Tieu R; Knoth RL; Fincher C; Malhotra M; Choi J
Epilepsy Behav; 2020 Jan; 102():106634. PubMed ID: 31783318
[TBL] [Abstract][Full Text] [Related]
14. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
Hansen RN; Nguyen HP; Sullivan SD
Epilepsy Res; 2013 Sep; 106(1-2):237-43. PubMed ID: 23726541
[TBL] [Abstract][Full Text] [Related]
15. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
Kesselheim AS; Bykov K; Gagne JJ; Wang SV; Choudhry NK
Neurology; 2016 Oct; 87(17):1796-1801. PubMed ID: 27683844
[TBL] [Abstract][Full Text] [Related]
16. Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy.
Moraes JS; Hepworth G; Ignatiadis S; Dharan A; Carne R; Seneviratne U; Cook MJ; D'Souza WJ
Epilepsy Behav; 2020 Mar; 104(Pt A):106883. PubMed ID: 32045874
[TBL] [Abstract][Full Text] [Related]
17. Applying a perceptions and practicalities approach to understanding nonadherence to antiepileptic drugs.
Chapman SC; Horne R; Eade R; Balestrini S; Rush J; Sisodiya SM
Epilepsia; 2015 Sep; 56(9):1398-407. PubMed ID: 26215092
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a third or later antiepileptic drug regimen according to epilepsy syndrome among adult patients.
Ito G; Okumura A; Kanemoto K
Epilepsy Res; 2017 Oct; 136():103-108. PubMed ID: 28822307
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.
Brittain ST; Wheless JW
Epilepsy Behav; 2015 Nov; 52(Pt A):31-6. PubMed ID: 26409125
[TBL] [Abstract][Full Text] [Related]
20. Focal epilepsies in adult patients attending two epilepsy centers: classification of drug-resistance, assessment of risk factors, and usefulness of "new" antiepileptic drugs.
Gilioli I; Vignoli A; Visani E; Casazza M; Canafoglia L; Chiesa V; Gardella E; La Briola F; Panzica F; Avanzini G; Canevini MP; Franceschetti S; Binelli S
Epilepsia; 2012 Apr; 53(4):733-40. PubMed ID: 22360822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
